|
2005 Pharmaceutical Reevaluation Results
2006.01.10
|
|---|
|
In accordance with Article 26-3 and Article 34, Paragraph 4 of the Pharmaceutical Affairs Act and the [Regulations on the Implementation of Drug Reevaluation (KFDA Notification)], a reevaluation was conducted for [7 vitamin therapeutic groups, 367 products] and [7 tonic therapeutic groups, 900 products] with results hereby announced.
Affected products include: Placein M Injection (Human Placenta Extract) Calibin Soft Capsules (Calcitriol) For inquiries regarding this notice:
Responsible Department: Daehan New Pharm R&D Division
Contact: 02-3415-7857 |


Home